المؤلفون: Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Marina Talamonti, Matteo Megna, Massimo Raspanti, Matteo Paolinelli, Katharina Hansel, Alessandra Narcisi, Andrea Conti, Clara De Simone, Marco Adriano Chessa, Alina De Rosa, Eugenio Provenzano, Michela Ortoncelli, Chiara Moltrasio, Rosaria Fidanza, Martina Burlando, Annalisa Tonini, Francesca Maria Gaiani, Lucia Simoni, Alessandro Zullo, Martina Fiocchi, Delia Colombo

المصدر: BMC Health Services Research, Vol 21, Iss 1, Pp 1-13 (2021)

مصطلحات موضوعية: Biologic, Secukinumab, Adalimumab, Ustekinumab, Ixekizumab, Costs, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1472-6963Test

الوصول الحر: https://doaj.org/article/bf7a33c77b234fa2ab263ac7a808782fTest

المؤلفون: Giovanni Pellacani, Annamaria Offidani, Aurora Parodi, Alina De Rosa, Martina Burlando, Maria Concetta Fargnoli, Alessandro Zullo, Emanuela Zagni, Federico Bardazzi, Eugenio Provenzano, Chiara Moltrasio, Lucia Simoni, Piergiorgio Malagoli, Delia Colombo, Andrea Conti, Luca Stingeni, Michela Ortoncelli, Giuseppe Argenziano, Salvatore Corrao, Annalisa Tonini, Francesca Gaiani, Katharina Hansel, Marina Talamonti, Matteo Megna, Ketty Peris, Matteo Paolinelli, Rosaria Fidanza, Gabriella Fabbrocini, Clara De Simone, Antonio Costanzo, Marco Adriano Chessa, Luca Bianchi, Alessandra Narcisi, Massimo Raspanti, Paolo Dapavo, Marco Romanelli, C. Carrera, M. Fiocchi, Silvana Ruffolo

المساهمون: Zagni, E., Bianchi, L., Fabbrocini, G., Corrao, S., Offidani, A., Stingeni, L., Costanzo, A., Pellacani, G., Peris, K., Bardazzi, F., Argenziano, G., Ruffolo, S., Dapavo, P., Carrera, C., Fargnoli, M. C., Parodi, A., Romanelli, M., Malagoli, P., Talamonti, M., Megna, M., Raspanti, M., Paolinelli, M., Hansel, K., Narcisi, A., Conti, A., De Simone, C., Chessa, M. A., De Rosa, A., Provenzano, E., Ortoncelli, M., Moltrasio, C., Fidanza, R., Burlando, M., Tonini, A., Gaiani, F. M., Simoni, L., Zullo, A., Fiocchi, M., Colombo, D., Zagni, Emanuela, Bianchi, Luca, Fabbrocini, Gabriella, Corrao, Salvatore, Offidani, Annamaria, Stingeni, Luca, Costanzo, Antonio, Pellacani, Giovanni, Peris, Ketty, Bardazzi, Federico, Argenziano, Giuseppe, Ruffolo, Silvana, Dapavo, Paolo, Carrera, Carlo, Fargnoli, Maria Concetta, Parodi, Aurora, Romanelli, Marco, Malagoli, Piergiorgio, Talamonti, Marina, Megna, Matteo, Raspanti, Massimo, Paolinelli, Matteo, Hansel, Katharina, Narcisi, Alessandra, Conti, Andrea, De Simone, Clara, Chessa, Marco Adriano, De Rosa, Alina, Provenzano, Eugenio, Ortoncelli, Michela, Moltrasio, Chiara, Fidanza, Rosaria, Burlando, Martina, Tonini, Annalisa, Gaiani, Francesca Maria, Simoni, Lucia, Zullo, Alessandro, Fiocchi, Martina, Colombo, Delia, Zagni E., Bianchi L., Fabbrocini G., Corrao S., Offidani A., Stingeni L., Costanzo A., Pellacani G., Peris K., Bardazzi F., Argenziano G., Ruffolo S., Dapavo P., Carrera C., Fargnoli M.C., Parodi A., Romanelli M., Malagoli P., Talamonti M., Megna M., Raspanti M., Paolinelli M., Hansel K., Narcisi A., Conti A., De Simone C., Chessa M.A., De Rosa A., Provenzano E., Ortoncelli M., Moltrasio C., Fidanza R., Burlando M., Tonini A., Gaiani F.M., Simoni L., Zullo A., Fiocchi M., Colombo D.

المصدر: BMC Health Services Research, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Health Services Research

مصطلحات موضوعية: Response rate, medicine.medical_specialty, Cost per responder, Biologic, Cost, Ixekizumab, Longitudinal Studie, Context (language use), Secukinumab, Severity of Illness Index, Antibodies, Indirect costs, Settore MED/35, Quality of life, Internal medicine, Psoriasis, Ustekinumab, Monoclonal, Adalimumab, Antibodies, Monoclonal, Longitudinal Studies, Quality of Life, Treatment Outcome, Italy, Humans, Biological Therapy, Real-world, medicine, health care economics and organizations, Psoriasi, Costs, business.industry, Health Policy, Research, medicine.disease, Public aspects of medicine, RA1-1270, Settore MED/35 - MALATTIE CUTANEE E VENEREE, business, Human, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eab7dfed4cbf604b67ba4615e87fc25Test
https://doaj.org/article/bf7a33c77b234fa2ab263ac7a808782fTest

المؤلفون: Zagni, Emanuela, Bianchi, Luca, Fabbrocini, Gabriella, Corrao, Salvatore, Offidani, Annamaria, Stingeni, Luca, Costanzo, Antonio, Pellacani, Giovanni, Peris, Ketty, Bardazzi, Federico, Argenziano, Giuseppe, Ruffolo, Silvana, Dapavo, Paolo, Carrera, Carlo, Fargnoli, Maria Concetta, Parodi, Aurora, Romanelli, Marco, Malagoli, Piergiorgio, Talamonti, Marina, Megna, Matteo

المصدر: BMC Health Services Research; 9/6/2021, Vol. 21 Issue 1, p1-13, 13p, 3 Charts, 2 Graphs

مصطلحات موضوعية: BIOTHERAPY, PHYSICIANS, PSORIASIS, LONGITUDINAL method, BIOLOGICALS, PSORIATIC arthritis, ATHEROSCLEROTIC plaque

مصطلحات جغرافية: ITALY